FDA inspection
BioCorRx Inc: FDA inspection ending Aug 14, 2020
FDA inspection 1127099 · No Action Indicated (NAI) · Anaheim, CA
Key facts
| Inspection ID | 1127099 |
|---|---|
| Firm | BioCorRx Inc |
| FEI number | 3016430589 |
| Address | 2390 E Orangewood Ave Ste 575 |
| City | Anaheim |
| State | CA |
| ZIP | 92806 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Aug 14, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data